as thyrotoxic.
Among subjective complaints palpitation is the most frequent; it can be referred to both tachycardia and overaction of the heart, and it is probably the latter which is more important in its causation. Dyspnoea of effort is fairly common and is found independently of heart failure. It may be due to the need of hyperventilation to cover the increased oxygen requirement (Fishberg, I940 (Fig. 2) . With the advent of cardiac failure the typical shape is lost; the enlargement of the conus straightens out the left heart border, the right auricle becomes greatly prominent, and the triangular shape of the heart is that found in heart failure from other causes, except fr6m hypertension. Pulmonary congestion, however, is not such a prominent feature as it is in heart failure due to mitral stenosis or hypertension (Fig. IB) .
Reduction in the size of the heart after subtotal thyroidectomy, sometimes quite pronounced, occurs in almost all patients whose congestive heart failure is relieved by it, and in some of those without heart failure, but with fibrillation, who revert to normal rhythm after the operation. In those with an enlarged heart and normal rhythm before the operation, the heart may either become smaller and the characteristic prominence of the pulmonary artery disappear, or the heart may enlarge after the operation. The latter happens in coincident heart disease, after rapid gain in weight, in post-operative myxoedema, and also for unknown reasons (Menard and Hurxthal, I932).
Electrocardiographic signs.
Tachycardia, auricular fibrillation, extrasystoles and myocardial changes are the features of the electrocardiogram in thyrotoxic heart disease. There is nothing characteristic in the electrocardiographic features singly, but the combination of some may result in records more suggestive of thyrotoxicosis than of any other heart disease. High-rate resting tachycardia, I40 or over, is rarely of neurogenic origin (Fig. 3) (Anderson, I932) .
Treatment.
Since the introduction of iodine as a preoperative measure, the mortality rate after subtotal thyroidFebruary, x945 49 POST-GRADUATE MEDICAL JOURNAL ectomy in hands of experienced surgeons has fallen from 15 per cent to I per cent (Joll, 1932; Dunhill, 1937; Linnell and Keynes, 1939) . No wonder that surgical treatment with its brilliant and lasting success has almost entirely replaced medical treatment.
Before the operation, patients who are in failure, or those with rapid auricular fibrillation, in addition to Lugol's Iodine (m5-mIo bis to t.i.d., for 2-3 weeks), should have digitalis as well. The digitalis tolerance in thyrotoxic patients is increased to more than double (Barker et In cardiac patients so prepared the operative risk may be slightly higher (2-3 per cent, Slesinger, 1939), than in those without cardiac complications, though in Likoff and Levine (i943) series of ninety-nine cases it was nil, while in those without heart involvement it amounted to 2-6 per cent. Recovery after successful operation is lasting, and follow-up series after many years showed no permanent cardiac damage which could have been related to thyrotoxicosis (Read, I932) . In addition to the thyrotoxic heart symptoms, others due to coexistent cardio-vascular disease (angina pectoris, hypertension) may also benefit by the operation which relieves the heart' from an additional strain. (Himsworth, 1944; Nussey, I944) . Further trials will show if treatment ever can be discontinued, and how far thiouracil can replace operation.
The Heart in Myxoedema
Myxoedema is much less of a cardiac problem than thyrotoxicosis for it is uncommon, and cardiac symptoms develop only in untreated cases years after the unmistakable external signs of the disease have been in evidence. As very few patients go untreated, myxoedema heart, as first described by Zondek in I918, is rare.
The metabolism in myxoedema is exactly the opposite to that of thyrotoxicosis, and so are the haemodynamic adjustments. The reduced oxygen consumption of the tissues reduces the demand on the heart; cardiac output is diminished with 20-50 per cent through both smaller stroke volume and bradycardia. The circulation is slowed to an extent never met outside congestive heart failure (Fishberg, 1940) , and the peripheral blood flow is decreased. Under thyroid treatment there is a progressive increase in these values, in proportion to the increase in basal metabolic rate.
Since the work of the heart is greatly reduced in myxoedema, the reason for cardiac enlargement and ultimate failure has to be sought outside these metabolic conditions.
The meagre pathological evidence shows that myxoedema predisposes to arteriosclerosis, and it is believed by many that the heart changes are primarily due to it. If this were true, failure and cardiac enlargement would not be reversible as they are in myxoedema. Besides, there is evidence that deficiency in thyroid secretion reduces the functional capacity of the heart muscle, as it reduces the strength and tonus of voluntary muscle, and thus may produce dilatation of the heart. Accumulation of myxoedema fluid, causing interstitial oedema in the heart muscle as proved by post mortem findings, may play an additional part in producing heart failure.
The incidence of heart failure in myxoedema is variously estimated in different series. 
